In recent years, the FDA has taken an increasingly active role in the growing digital health industry: developing new regulatory frameworks, reframing development standards, and offering a wide array of industry guidance. Led by commissioner Scott Gottlieb, the FDA has pointedly endeavored to actively adapt to the ever-changing health tech industry.
This week’s digital health news…
In recent years, venture capitalists, technology developers, and medical providers alike have begun tapping into a long-neglected demographic: women’s health. Dubbed by industry insiders as ‘FemTech,’ the growing sub-market encompasses software, diagnostic tools, wearable trackers, and additional online services that utilize digital technology to improve women’s health.
Radio Frequency Identification is a technology that uses radio waves for data collection and transfer, often without human intervention—and it is being increasingly used by healthcare organizations to potentially reduce risk.
The Food and Drug Administration has approved the Zephyr Endobronchial Valve (Zephyr Valve), a device to treat breathing difficulty associated with severe emphysema.
A study published in the journal Autism Research provides hope that virtual reality can buttress social skills of autistic students.
Medical researchers have come up with an imaging technique that captures and magnifies the brain in motion, in real time, every time the heart beats. The significance of this event: it offers an encouraging diagnostic tool for catching difficult-to-spot conditions such as concussions and aneurysms—before they become life threatening.
It is neither science fiction nor scientific fact. Still, research is progressing that would allow us to make our brains see and feel things that they do not actually experience. Scientists have even discovered how to manipulate the brain into seeing pictures we do not physically see, and even eliminating uncomfortable sensations such as pain.